baber/WOPTO huggingface dataset:
Patent NZ-514225-A (NZ)
Title: Air and water purification using continuous breakpoint halogenation and peroxygenation
Inventor: MARTIN ROY
IPC: C02F1/00
Filed: 2000-02-24
Abstract: A process for optimising the rate of oxidation using halogen, e.g. chlorine donors to prevent the accumulation of undesirable chlorinated by-products is disclosed, wherein the feed rate of a chlorine donor is controlled for maintaining a desired ORP, the rate of oxidation is sufficient to prevent the accumulation of the undesirable by-products. Treatment by this process removes the by- products from the water and surrounding air by maintaining continuous breakpoint halogenation conditions.
Patent NZ-519758-A (NZ)
Title: Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines and their use as pharmaceutical compositions
Inventor: GRAUERT MATTHIAS
IPC: A61K31/445
Filed: 2000-11-21
Abstract: Described are 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines compounds of formula 1, for which the substituents are defined herein. The compounds are used in the manufacture of medicaments for the treatment of diseases in which blockade of the voltage-dependent sodium channel may be of therapeutic value.
Patent NZ-520921-A (NZ)
Title: Gravity flow faucet
Inventor: SLOTHOWER ERICH D
IPC: E03C1/04
Filed: 2001-02-23
Abstract: Faucets are disclosed which provide a gentle, gravity driven cascading flow of water.  A mixing valve (20) is positioned in a faucet body (12) which permits exiting water to flow outside the mixing valve inside the faucet housing.  The valve unit is thus partially submerged by the water that has passed through it.  The pool of water helps to create a more gentle uniform flow of water.  A flow regulator can be positioned in the fluid outlet (14) of the valve.
Patent NZ-521157-A (NZ)
Title: Improvements relating to dimmers
Inventor: STUART ROBERT JAMES
IPC: H02J7/06
Filed: 2002-09-03
Abstract: Disclosed is a dimmer for controlling the application of mains power to a load includes switching means switchable between on and off states to connect and disconnect the mains power to and from the load respectively during an adjustable period of each half of the mains power cycle, control circuitry which generates a control signal to control the state of the switching means during each half of the mains power cycle in accordance with the adjustable period and power supply circuitry adapted to power the control circuitry, the power supply circuitry being charged by the mains power in accordance with the voltage potential across the switching means.
Patent NZ-521212-A (NZ)
Title: Fan type shade apparatus for side fitting to a child conveyance
Inventor: HORVATH TIBOR JOSEPH
IPC: B60N2/90
Filed: 2002-09-05
Abstract: A shade apparatus (1) for a child conveyance (2) comprising a support (3) attachable to a side (4) of a child conveyance (2) and a shade member (5) hingedly connected by a crease line to the support (3). The support (3) includes two mounts (12, 13) comprising hook and loop fasteners for attaching to the side (4) of the conveyance (2). The shade member (5) is movable relative to the support (3) between a retracted position (as seen with the left-hand apparatus (1)) whereby ready access to an occupant of the conveyance (1) is permitted and an operative position (as seen with the right-hand apparatus (1)) whereby the shade member (5) shields a head, torso and upper limbs of the occupant
Patent NZ-521853-A (NZ)
Title: Stabilized pharmaceutical compositions containing a calcium blocker
Inventor: WAKIYAMA NAOKI
IPC: A61K31/4439
Filed: 2001-04-10
Abstract: Pharmaceutical compositions containing calcium blockers and an alkaline material added until the pH of the composition is at least 8. Said pH affords stability characteristics (e.g. storage stability) to the composition.
Patent NZ-532665-A (NZ)
Title: Neisseria meningitidis antigens and compositions
Inventor: FRASER CLAIRE
IPC: A61K38/00
Filed: 1999-04-30
Abstract: Proteins isolated from Neisseria meningitidis that are useful antigens for vaccines and/or diagnostics, including the amino acid sequences and the corresponding nucleotide sequences are disclosed.
Patent NZ-540035-A (NZ)
Title: Pyrazine-based tubulin inhibitors
Inventor: BURNS CHRISTOPHER JOHN
IPC: C07D405/06
Filed: 2003-12-11
Abstract: Disclosed is a compound of formula I or pharmaceutically acceptable prodrugs, salts, hydrates, solvates, crystal forms or diastereomers thereof, wherein: R1 is H, C1-6alkyl, C1-6alkylNR5R6, C1-6alkylNR5COR6, C1-6alkylNR5SO2R6, C1-6alkylCO2R5, C1-6alkylCONR5R6, where R5 and R6 are each independently H, C1-4alkyl, aryl, hetaryl, C1-4alkylaryl, C1-4alkylhetaryl or may be joined to form an optionally substituted 3-8 membered ring optionally containing an atom selected from O, S, NR7 and R7 is selected from H, C1-4alkyl; R2, R3 and R4 are each independently H, halogen, C1-4alkyl, OH, OC1-4alkyl, CF3, OCF3, CN, C1-4alkylNR8R9, OC1-4alkylNR8R9, OCONR8R9, NR8R9, NR8COR9, NR10CONR8R9, NR8SO2R9, COOR8, CONR8R9; and R8, R9 are each independently H, C1-4alkyl, C1-4alkyl cycloalkyl, or may be joined to form an optionally substituted 3-8 membered ring optionally containing an atom selected from O, S, NR11; R10 and R11 are independently selected from H, C1-4alkyl, CF3; alternatively, two of R2, R3 and R4, when located on adjacent carbon atoms, may be joined to form a ring system as depicted in the specification; Q is C1-4alkyl; W is selected from C2-4alkyl, C2-6alkenyl; where C2-4alkyl or C2-6alkenyl may be optionally substituted with C1-4alkyl, OH, OC1-4alkyl, NR15R16; and R15, and R16 are each independently H, C1-4alkyl, C1-4alkyl cycloalkyl, C1-4alkyl cyclohetalkyl, aryl, hetaryl, or may be joined to form an optionally substituted 3-8 membered ring optionally containing an atom selected from O, S, NR17 and R17 is selected from H, C1-4alkyl; A is aryl, hetaryl optionally substituted with 0-3 substituents independently chosen from halogen, C1-4alkyl, CF3, aryl, hetaryl, OCF3, OC1-4alkyl, OC2-5alkylNR18R19, Oaryl, Ohetaryl, CO2R18, CONR18R19, NR18R19, C1-4alkylNR18R19, NR20C1-4alkylNR18R19, NR18COR19, NR20CONR18R19, NR18SO2R19; and R18, R19 are each independently H, C1-4alkyl, C1-4alkyl cyclohetalkyl, aryl, hetaryl, C1-4alkyl aryl, C1-4alkyl hetaryl, or may be joined to form an optionally substituted 3-8 membered ring optionally containing an atom selected from O, S, NR21; and R20 is selected from H, C1-4alkyl; and R21 is selected from H, C1-4alkyl; and Y is selected from H, C1-4alkyl, OH, NR22R23, and R22, and R23 are each independently H, C1-4alkyl. The compounds may be used to prepare a medicament for the treatment of a hyperproliferation-related disease state. Reference has been directed by the Commissioner under Section 14 to Patent Specification 537155.
Patent NZ-541344-A (NZ)
Title: An improved smelting process for the production of iron
Inventor: NG COLETTE MARIA
IPC: C21C5/56
Filed: 2004-01-20
Abstract: A process for producing iron metal and slag by smelting iron-containing source material, having iron present as oxide, in a partially metallised state or a combination thereof, in a reactor containing a molten bath comprising or having a slag phase, wherein the process comprises the steps of: (a) injecting fuel/reductant and oxygen-containing gas into the slag, by at least one top-submerged lance, to generate heating and reducing conditions in at least one reducing region in the bath; (b) feeding the source material to the reactor, together with additional reductant and with flux, at or adjacent to the at least one reducing region, whereby the source material is subjected to smelting reduction which generates combustion gases comprising CO and H2; (c) controlling the rates of injection of the oxygen-containing gas and fuel/reductant by said at least one lance to achieve required, sufficient reducing conditions; and (d) post-combusting, in the reactor above the bath, the combustion gases generated by the smelting; wherein the controlling of step (c) is conducted to result in the injected oxygen-containing gas having an oxygen content of from about 40 volume% to about 100 volume% and sufficient for a degree of combustion in excess of 60 wt% of the fuel/reductant injected by the at least one lance.
Patent NZ-543147-A (NZ)
Title: Method of manufacturing oriented films from alloyed thermoplastic polymers, apparatus for such manufacture and resulting products
Inventor: RASMUSSEN OLE-BENDT
IPC: B29C48/10
Filed: 2004-04-26
Abstract: A blend of two partly incompatible polymers is extruded to form a film under conditions such that the alloy in the blend comprises fibrils extending mainly in one direction, the width and thickness of each fibril having a mean lower than 5 m, the fibrils being formed of the polymer component having a higher melting point, and the fibrils being surrounded by a matrix of the second polymer, which has a lower coefficient of elasticity. The special morphology is achieved by providing grids in a grid chamber upstream of the exit orifice of the extrusion die, and by sequential hot stretching at a temperature at which the higher melting polymer is at least partly crystalline, and cold stretching, at which both polymers are substantially solid. The second, cold stretching step, is carried out under conditions to give an elongation at break at 20 DEG C of at least 25%. The films are of particular value for forming crosslaminates having high shock resistance. Preferably the polymer forming fibrils is polypropylene and the polymer forming the matrix is an ethylene polymer, preferably LLDPE.
Patent NZ-543923-A (NZ)
Title: Pho3-18 for a theraputic use, particulary in bacterial infection.
Inventor: HUGHES MARTIN JOHN GLENTON
Filed: 1999-12-22
Abstract: Disclosed is the use of Pho3-18 (SEQ ID 21) in the treatment of Group B Streptococcus and other infections. The protein, or functional fragments thereof, may be useful in the preparation of therapeutics, e.g. vaccines to immunise a patient against microbial infection.
Patent NZ-545460-A (NZ)
Title: A composition comprising hydrogen peroxide, glycolic acid and less than 50 weight percent water, and the use thereof in removing or dissolving a contaminant from an environment
Inventor: MCCLUNG JAMES E
IPC: D21C9/10
Filed: 2001-08-03
Abstract: A process for reducing the concentration of a contaminant in a waste treatment process is disclosed. The process includes selecting a composition which comprises of contacting selected ratios of hydrogen peroxide, glycolic acid, and low solids water. The low solids water is present in an amount of at least around fifty percent based on the total weight of the hydrogen peroxide, glycolic acid. The low solids water used in the above process comprises less than about ten parts per million dissolved solids.
Patent NZ-546790-A (NZ)
Title: Human antibodies that bind human TNF(alpha)
Inventor: SALFELD JOCHEN G
IPC: G01N33/68
Filed: 1997-02-10
Abstract: Human antibodies, preferably recombinant human antibodies, that specifically bind to human tumour necrosis factor a (hTNFa) are provided. These antibodies have high affinity for hTNFa ( Kd of 10-8 M or less), a slow off rate for hTNFa dissociation (Koff of 10-3 sec-1 or less) and neutralize hTNFa cytotoxicity in a standard in vitro L929 assay with an IC50 of 10-7M or less. The antibodies, or antibody portions may be useful for inhibiting hTNFa activity in a human subject suffering from a disorder in which hTNFa activity is detrimental. Such disorders include sepsis, autoimmune diseases, infectious diseases, transplant rejection, malignancy, pulmonary disorder, intestinal disorder, cardiac disorder and inflammatory bone disorders.
Patent NZ-547469-A (NZ)
Title: 6-Amino-1H-indazole and 4-aminobenzofuran compounds as phosphodiesterase 4 inhibitors
Inventor: SCHUMACHER RICHARD A
Filed: 2003-07-18
Abstract: Disclosed is a compound of formula I wherein: R1 is H, alkyl, cycloalkyl, or heterocyclyl; R2 is H or alkyl; R3 is alkyl, a partially unsaturated carbocycle-alkyl group, arylalkyl or a heterocycle-alkyl group; and R4 is aryl or heteroaryl; wherein all substituents are as defined in the specification. Compounds of the type disclosed are phosphodiesterase 4 (PDE4) inhibitors useful for the treatment of various disorders such as psychosis, memory impairment, allergic or inflammatory disease, neurodegeneration and drug addiction.
Patent NZ-550216-A (NZ)
Title: Substituted 1,2,3,4-tetrahydroisoquinoline derivatives
Inventor: AISSAOUI HAMED
IPC: C07D217/18
Filed: 2005-02-23
Abstract: Disclosed is a compound of formula (I), and salts, solvates, and stereoisomers thereof, wherein R1 and R2 are hydrogen or C1-C4 alkoxy, R3 is C1-C6 alkyl, X is -CH- or -N-. Also disclosed is the use of the compound to treat diseases such as eating disorders or sleeping disorders.
Patent NZ-552736-A (NZ)
Title: Carrier conjugates of GNRH-peptides
Inventor: BACHMANN MARTIN
IPC: C07K7/23
Filed: 2005-08-04
Abstract: Disclosed is a composition comprising: (a) a virus like particle (VLP), wherein said VLP is a VLP of an RNA-phage, and (b) at least one gonadotrophin releasing hormone (GnRH) peptide; wherein a) and b) are linked with one another, and wherein said VLP (a) is linked with the at least one GnRH-peptide (b) through at least one non-peptide covalent bond; and wherein said composition further comprising a linker (c) between said VLP and said at least one GnRH-peptide and wherein said linker consists of less than 4 amino acids.
Patent NZ-552759-A (NZ)
Title: Message transfer system and message transfer method
Inventor: SAWADA HISANORI
IPC: H04M11/00
Filed: 2005-06-30
Abstract: A message transfer system is provided. The system includes means for receiving transmission request information containing information specifying a message destination, and message data to be transmitted to the message destination, from a message sender equipment; means for converting the message data into transmitting message data in a predetermined format; means for adding communication address information corresponding to the destination information, to the transmitting message data resulting from the conversion, and outputting the resultant; and means for, when detecting predetermined restricted object data in the message data in the transmission request information received, performing a control not to transmit the restricted object data.
Patent NZ-566004-A (NZ)
Title: Indoor unit of air conditioner
Inventor: OZAWA TETSURO
IPC: F24F3/16
Filed: 2006-08-29
Abstract: An indoor machine of an air conditioner, comprising a front air filter (5A) and an upper air filter (5B) installed to face a front suction port (4) and an upper suction port (6), a front suction frame (7A) holdingly supporting the front air filter (5A) movably in the direction of the upper suction port (6), an upper suction frame (7B) holdingly supporting the upper air filter (5B) movably in the direction of the front suction port (4), a front moving mechanism reciprocatingly moving the front air filter (5A), an upper moving mechanism reciprocatingly moving the upper air filter (5B), and a cleaning unit (Z) having a rotary brush removing dust from the front air filter (5A) and the upper air filter (5B) and a dust collection part collecting the dust. The front moving mechanism and the upper moving mechanism alternately move the front air filter (5A) and the upper air filter (5B) to the cleaning unit (Z) for cleaning.
Patent NZ-566739-A (NZ)
Title: Quinoline derivatives for inhibiting amyloid deposits
Inventor: KONG XIANQI
IPC: A61K31/445
Filed: 2000-05-24
Abstract: Disclosed is the use of a compound selected from: 8-hydroxy-5-quinolinesulfonic acid,8-hydroxy-7-iodo-5-quinolinesulfonic acid, 5-chloro-8-quinolylmethylsulfonic acid, 5,8-dibromo-6-quinolylmethylsulfonic acid, 8-ethoxy-5-quinolinesulfonic acid, 5-chloro-6-quinolylmethylsulfonic acid, quinoline yellow, 5-bromo-6-quinolylmethylsulfonic acid, 7-bromo-8-hydroxy-5-quinolinesulfonic acid, 7-chloro-8-hydroxy-5-quinolinesulfonic acid, 5-chloro-8-hydroxy-7-quinolinesulfonic acid, 5-bromo-8-hydroxy-7-quinolinesulfonic acid, 8-hydroxy-2-methyl-5-quinolinesulfonic acid, 8-hydroxy-2-methyl-5,7-quinolinedisulfonic acid, 5-chloro-8-hydroxy-2-methyl-7-quinolinesulfonic acid, 5-bromo-8-hydroxy-2-methyl-7-quinolinesulfonic acid, 2,6-quinolyldimethyldisulfonic acid, 5-chloro-2,6-quinolyldimethyldisulfonic acid, 8-methoxy-5-quinolinesulfonic acid, 8-methoxy-5-[N-(2-N',N'-diethylethylamino)]quinolinesuIfonamide, 8-methoxy-5-[N-(2-N',N'-indoIineethylamino)]quinolinesulfonamide, and 4-[2-( 1,2,3,4,5,6,7,8-octahydroisoquinolinyl)]-1-butanesulfonic acid, or a pharmaceutically acceptable ester, acid or salt thereof, to treat a disease state characterized by lAPP-associated amyloid deposits, such as in the pancreatic islets.
Patent NZ-567892-A (NZ)
Title: Heterocyclic modulators of ATP-binding cassette transporters containing cycloalkyl or heterocycloalkyl groups
Inventor: HADIDA RUAH SARA
IPC: A61K31/4418
Filed: 2006-11-08
Abstract: Disclosed are compounds useful as modulators of ATP-Binding Cassette ('ABC') transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator ('CFTR'), wherein the substituents are as defined in the specification, and pharmaceutically acceptable compositions thereof. Preferred are compounds of formula (I'-A) and (I'-B), and 1-benzo[1,3]-dioxol-5-yl-N-[2-pyridyl]-cyclopropane-1-carboxamides of formulae (V-A) and (V-B).
Patent NZ-570181-A (NZ)
Title: 1,3,8-Triazaspiro[4.5]decan-4-one derivatives useful for the treatment of ORL-1 receptor mediated disorders
Inventor: PAN KEVIN
IPC: A61K31/435
Filed: 2002-04-05
Abstract: Disclosed is a compound of the formula (I) and pharmaceutically acceptable salts thereof wherein A is selected from the group consisting of phenyl, a five membered heteroaryl and a six membered heteroaryl; R6 is selected from the group consisting of optionally substituted heteroaryl and heterocycloalkyl and wherein the rest of the substituents are disclosed within. Also disclosed is the use of the above compound of formula (I) for the preparation of a medicament for use in treating a disorder mediated by the ORL-1 receptor. (62) Divided Out of 552900
Patent NZ-576927-A (NZ)
Title: Progesterone receptor antagonists
Inventor: FUHRMANN ULRIKE
IPC: A61K31/567
Filed: 2007-11-14
Abstract: Disclosed is a progesterone receptor antagonist compound of formula I, wherein: R1 can be a hydrogen atom and R2 a hydroxyl group or R1 and R2 together can be an oxo group. Specific compounds disclosed include: 11beta-[4-(1,2-dihydroxyethyl)phenyl]-20,20,21,21,21-pentafluoro-17-hydroxy-19-nor-17alpha-pregna-4,9-dien-3-one; and 20,20,21,21,21-pentafluoro-17-hydroxy-11beta-[4-(hydroxyacetyl)phenyl]-19-nor-17alpha-pregna-4,9-dien-3-one. Further disclosed is a pharmaceutical composition comprising a compound of formula I, and the use of the compound of formula I in the manufacture of a medicament for the treatment of endometriosis, myomas, hormone-dependent tumours, or for female contraception.
Patent NZ-578760-A (NZ)
Title: Switch plate with a button surround that can releasably mount a switch to a housing with a rotating locking means
Inventor: BUDDEN PETER
IPC: H02B1/40
Filed: 2009-07-31
Abstract: An electrical switch assembly is disclosed. Components of the switch assembly are able to be releasably connected to a mounting plate (30). The assembly comprises a mounting plate (30) including a first opening (33). A button surround including a second opening is securable to the mounting plate with a switch (34), including a button for operating the switch, is securable relative to the mounting plate (30). The button is accessible through the first opening and the second opening. A cover plate, including a third opening, is securable to the mounting plate (30) such that the button is accessible through the third opening. The button surround and the switch (34) are adapted to be secured to each other; the switch (34) includes a housing which is attachable to the button surround. Both the housing and button surround both form a rotary lock attachment means to allow the housing to be attached to the button surround using a rotating action.
Patent NZ-583580-A (NZ)
Title: Process for production of 1-(3-(2-(1-benzothiophen-5-yl)-ethoxy)propyl)azetidin-3-ol or salts thereof
Inventor: SAITOH AKIHITO
IPC: C07D333/54
Filed: 2006-03-27
Abstract: Disclosed is a process for production of 1-(3-(2-(1-benzothiophen-5-yl)ethoxy)propyl)azetidin-3-ol or salts thereof by subjecting 1-(3-(2-(1-benzothiophen-5-yl)ethoxy)propionyl)azetidin-3-ol to reduction reaction with an addition of activator in the presence of alkali metal borohydride (such as sodium borohydride), wherein the activator is at least one compound selected from a protonic acid (such as sulphuric acid, hydrogen chloride and trifluoroacetic acid) a methylating agent (such as dimethyl sulphate) and a silylating agent (such as trimethylsilyl chloride). (62) Divided Out of 561672
Patent NZ-585659-A (NZ)
Title: Streaming non-interactive video content and, in response to a viewer command, transitioning to interactive content similar to the non-interactive content
Inventor: PERLMAN STEPHEN G
IPC: H04N7/173
Filed: 2008-12-04
Abstract: 585659 Disclosed is a method of providing streaming interactive video. The method includes delivering linear video content, which comprises a live action movie, from one or more hosting service centres (210) to one or more client devices (415) associated with one or more users that are remote from the hosting service centres (210). In response to a first user input, the live action movie is paused and interactive content is delivered to a client device (415) of the user from the one or more hosting service centres (210). The interactive content is delivered to the client device (415) over the internet (410) as compressed streaming interactive video. The interactive video is linked to the linear video content dynamically and includes photorealistic 3D scenes that are animated from the live action movie. These scenes are generated in real time by one or more servers (402) running a twitch video game or application at the one or more hosting service centres (210). The compressed streaming interactive video is compressed with latency sufficiently low that the user interacting with the twitch video game or application perceives its responses to be as instantaneous as if the twitch game or application were running on a client device local to the user.
Patent NZ-585872-A (NZ)
Title: Compact image intensifier tube and night vision system fitted with such a tube
Inventor: LAVOUTE PASCAL
IPC: H01J31/50
Filed: 2008-12-12
Abstract: Disclosed is an image intensifier tube (1) for receiving photons from an external environment and outputting a visible image. The tube (1) is comprised of a tube body (40), a photocathode (15), multiplying means (20-24) and a phosphorus screen (31). The tube body delimits a vacuum chamber (2) that is closed in a sealed manner at a first end by an input device (10) of an incident light signal and a second end opposite the first end along the axial direction (A) of the tube (1) by a light signal output device (30). The photocathode (15) is arranged on an internal surface of the input device (10) and receives photons to generate photoelectrons. The multiplying arrangement (20-24) receives the photoelectrons and outputs secondary electrons in response. The phosphorus screen (31) is arranged on the internal surface of the output device (30) and receives the secondary electrons and provides a visible image in response. The tube body (40) is comprised of a monolithic multilayer ceramic substrate arranged between the input device (10) and the output device (30). The substrate is fixed in a sealed manner to the input device (10) and the output device (30), on which the multiplying means (20-24) are fixed, and adapted to bring the multiplying means (20-24) to different electrical potentials.